Mobility Devices for Huntington Market Size (2023 - 2030):

The Global Mobility Devices for Huntington Market was valued at USD 701.59 million and is projected to reach a market size of USD 1076.01 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 6.3%. 

Huntingon's disease, a progressive brain disorder, causes uncontrolled movements, emotional confrontations, and cognitive impairment. Early warning signs of this affliction encompass moodiness, depression, little involuntary movements, coordination issues, and challenges with memory and decision-making. Most individuals with Huntington's disease also undergo chorea (involuntary jerking or twitching movements). As the disease progresses, these movements become more apparent and noticeable, impacting walking, speech, and swallowing. Furthermore, the most prevalent form of this disorder, adult-onset Huntington's disease, generally emerges during an individual's thirties or forties. Individuals with this condition live for 15-20 years after the first indications and symptoms appear.

A rarer form of Huntington's disease, referred to as the juvenile form, initiates during childhood or adolescence. This condition not only causes mobility issues but also disrupts mental and emotional states. Other warning signs of the juvenile form encompass slow movements, clumsiness, frequent falling, rigidity, slurred speech, and drooling. As cognitive abilities decline, academic performance also suffers. In addition, around 30%-50% of children with this condition go through seizures. In contrast to the adult-onset type, the juvenile form advances more swiftly, and those affected usually live for about 10-15 years after the first signs manifest.

Global Mobility Devices for Huntington Market Drivers:

The growing prevalence of Huntington's disease is fueling the growth of the Global Mobility Devices for Huntington Market.

The rising incidence of Huntington's disease in regions like the U.S.A. and major European nations is a significant factor boosting the market's expansion. Although there is currently no known treatment for this inherited neurodegenerative disorder, its symptoms can be effectively managed. One of the primary physical symptoms is chorea (involuntary jerky movements), which affects facial and limb muscles and worsens over time. Approx. 41,000 Americans exhibited symptoms of this affliction in 2021, and more than 200,000 individuals are at risk of inheriting it, as per the Huntington's Disease Society of America (HDSA). As the disease becomes more prevalent, the demand for better assistive devices is estimated to increase. Therefore, this factor propels the demand for mobility devices for Huntington's disease.

The rising awareness and government support are other factors contributing to the growth of the Global Mobility Devices for Huntington Market.

The increasing apprehensions about Huntington's disease have led the masses to look after their health and diet. Prominent companies are devoting significant attention to making advancements in technology, leading to the development of novel and enhanced personal mobility devices that are more effective in addressing the signs of Hutington's disease. Governments in developed economies have also increased their healthcare expenditure, leading to an augmenting demand for Huntington's disease mobility devices. Therefore, this factor also propels the demand for mobility devices for Huntington's disease.

Global Mobility Devices for Huntington Market Challenges:

The Global Mobility Devices for Huntington Market is encountering obstacles, primarily concerning high cost, limited awareness, and lack of reimbursement. Mobility devices for Huntingon's disease can be pricey, making it challenging for individuals to purchase them. In some nations, there is limited awareness about Huntingdon's disease among the general public and the treatments available. Moreover, in many nations, insurance coverage for Huntingdon's disease mobility devices may be restricted, making it challenging for individuals to access the devices. Thus, these hindrances curtail the progress of the Global Mobility Devices for Huntington Market.

Global Mobility Devices for Huntington Market Opportunities:

Global Mobility Devices for Huntington Market presents several prospects, namely, government initiatives and a growing emphasis on home healthcare. Governments of respective nations are taking measures to enhance the lives of individuals with Huntingdon's disease. These measures encompass research grants, financial assistance for mobility devices, and spreading awareness concerning the disease. Furthermore, with the rise of telemedicine (remote diagnosis and treatment of patients through telecommunications technology) and the trend toward home-based healthcare, there is an augmenting demand for mobility devices for home usage. With these, businesses can expand their product offerings, broaden their customer base, and drive a notable increase in their overall revenue.

COVID-19 Impact on the Global Mobility Devices for Huntington Market:

The Global Mobility Devices for Huntington Market has been considerably influenced by the COVID-19 outbreak. As a result of rigorous lockdowns, travel restrictions, and social distancing measures, the demand for mobility devices waned. Disruptions in the supply chains highly affected the expedited manufacturing and distribution of mobility devices for Huntington's disease. Moreover, amid the pandemic, non-urgent medical appointments and elective surgeries were postponed or canceled, causing some individuals with Huntington's disease to delay acquiring new mobility devices or prolong the use of their existing ones. These factors negatively impacted the market's growth. Despite these challenges, the market is projected to rebound alongside the global recovery from the pandemic.

Global Mobility Devices for Huntington Market Recent Developments:

• In December 2021, Invacare Corporation unveiled its strategic realignment with EMEA & APAC businesses under a single head to streamline operations and enhance the customer experience.

• In November 2021, Sunrise Medical LLC., a firm that devises and manufactures mobility devices, launched ZIPPIE Sphynx, an on-the-go, compact, and easily movable wheelchair that can fit within a car's trunk as per the client's requirements. 

• In August 2021, Falcon Mobility unveiled the Ultra-Lite 2 electric wheelchair that is formulated to be lightweight and easy to operate. 

MOBILITY DEVICES FOR HUNTINGTON MARKET REPORT COVERAGE:

Global Mobility Devices for Huntington Market Segmentation:

Global Mobility Devices for Huntington Market Segmentation: By Product Type

• Walkers

• Canes

• Crutches

• Wheelchairs

• Mobility Scooters

Based on the Product Type, the Wheelchairs segment occupied the highest market share in the year 2022. The growth can be ascribed to the constant improvements and innovation in the formulation and functionality of mobility devices, notably wheelchairs. Manufacturers are working on improvised features for wheelchairs, encompassing, strong wheels, cutting-edge maneuverability, and prototypes with weight-shifting capabilities for increased comfort and reliability. Furthermore, by permitting individuals with Huntington's disease to move chairs with electric controls, the development of electric wheelchairs has substantially diminished the burden on them.

Global Mobility Devices for Huntington Market Segmentation: By End-Use

• Hospitals & Clinics

• Long-term Care Centres

• Home-Care Settings

Based on the End-Use, the Home-Care Settings segment occupied the highest market share in the year 2022. The growth can be ascribed to the rising incidence of Huntington's disease among the geriatric population, leading to an increased need for mobility aids at home. This trend is envisaged to fuel the adoption of personal mobility devices among the elderly shortly due to restricted independent mobility, bolstering the growth of the home-care settings segment during the forecasted period 2023-2030.

Global Mobility Devices for Huntington Market Segmentation: By Region

• North America

• Europe

• Asia-Pacific

• South America

• Middle East & Africa

Based on the Region, North America occupied the highest share of the Global Mobility Devices for Huntington Market in the year 2022. The growth can be ascribed to a rise in the prevalence of age-associated diseases (Huntington's disease), advancements in healthcare infrastructure in nations, such as the United States and Canada, growing government support, and increased healthcare expenditure. Furthermore, North America is home to several prominent market players, including Invacare Corporation, Medline Industries, LP, Karman Healthcare Inc., Pride Mobility Products Corporation, and Hoveround Corporation.

The region of Europe is anticipated to expand at the quickest rate over the forecast period 2023-2030 owing to an increase in the elderly population, rising awareness regarding personal mobility devices, an increase in cases of Huntington's disease, improved access to healthcare services, and the strong presence of significant market players, including Sunrise Medical GmbH, Permobil AB, and Meyra GmbH.

Global Mobility Devices for Huntington Market Key Players:

1. Invacare Corporation (United States)

2. Medline Industries, LP (United States)

3. Karman Healthcare Inc. (United States)

4. Pride Mobility Products Corporation (United States)

5. Sunrise Medical GmbH (Germany)

6. Permobil AB (Sweden)

7. Meyra GmbH (Germany)

8. Etac AB (Sweden)

9. Hoveround Corporation (United States)

10. Handicare Group AB (Sweden)